Clinical Trial: Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets

Brief Summary: The purpose of this study is to investigate the efficacy and safety of oral phosphate (Z-521) in subjects with primary hypophosphatemic rickets.

Detailed Summary:
Sponsor: Zeria Pharmaceutical

Current Primary Outcome:

  • Serum ALP level [ Time Frame: 6 month ]
  • Serum phosphate level [ Time Frame: 6 month ]


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Zeria Pharmaceutical

Dates:
Date Received: November 7, 2010
Date Started: September 2010
Date Completion:
Last Updated: September 30, 2013
Last Verified: September 2013